Background
==========

CD4^+^T cells lacking the costimulatory molecule CD28 have been described in both elderly individuals and in several chronic inflammatory disorders, one being rheumatoid arthritis (RA).

Objective
=========

We characterized such CD28nullCD4^+^T cells from RA patients in order to identify surface markers correlating with function.

Methods
=======

Peripheral blood mononuclear cells were analyzed for surface marker expression by flow cytometry and *in vitro*cultures were set up for functional studies.

Results
=======

One-third of the RA patients had a persistent and expanded CD28null population, which comprised up to half of the CD4^+^T cells in peripheral blood. Functionally, CD28nullCD4^+^T cells were potent effector memory cells with regard to their proliferation and cytokine secretion profiles. This functional capacity correlated with a hitherto unpublished surface phenotype, the cells being uniformly CCR7-negative and CD43high. In addition, we re-evaluated previously suggested cell surface markers, and found CD57 and CD11b expressed on the majority of these NKT-like CD4^+^T cells. When combining phenotypic and functional analyses of subpopulations of the CD28nullCD4^+^T cells a new terminally differentiated T cell population was identified.

Conclusion
==========

We believe that in the balanced immune system of healthy individuals, CD28nullCD4^+^T cells are under homeostatic control, whereas in an unbalanced immune system such as in autoimmune disease CD28nullCD4^+^T cells are allowed to expand and have the capacity to enhance ongoing inflammatory reactions.
